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Abstract
Symbiotic bacterial communities can protect their hosts from infection by patho-
gens. Treatment of wild individuals with protective bacteria (probiotics) isolated
from hosts can combat the spread of emerging infectious diseases. However, it is
unclear whether candidate probiotic bacteria can offer consistent protection across
multiple isolates of globally distributed pathogens. Here, we use the lethal amphib-
ian fungal pathogen Batrachochytrium dendrobatidis to investigate whether probiotic
richness (number of bacteria) or genetic distance among consortia members influ-
ences broad-scale in vitro inhibitory capabilities of probiotics across multiple isolates
of the pathogen. We show that inhibition of multiple pathogen isolates by individual
bacteria is rare, with no systematic pattern among bacterial genera in ability to inhi-
bit multiple B. dendrobatidis isolates. Bacterial consortia can offer stronger protec-
tion against B. dendrobatidis compared to single strains, and this tended to be more
pronounced for consortia containing multiple genera compared with those consist-
ing of bacteria from a single genus (i.e., with lower genetic distance), but critically,
this effect was not uniform across all B. dendrobatidis isolates. These novel insights
have important implications for the effective design of bacterial probiotics to
mitigate emerging infectious diseases.
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1 | INTRODUCTION
The last 50 years has seen the emergence of several virulent wildlife
pathogens with broad host ranges (Tompkins, Carver, Jones,
Krkosek, & Skerratt, 2015). These emerging infectious diseases have
decimated wildlife populations globally and are major contributors to
the current global loss of biodiversity (e.g., McCallum, 2012; Skerratt
et al., 2007). Broad-scale treatments and/or prophylaxis for such
pathogens are often lacking for wild animals (Garner et al., 2016;
Sleeman, 2013). Developing such treatments is often complicated by
broad variation in genetic and phenotypic traits such as virulence
exhibited by these pathogens (e.g., Farrer et al., 2011; de Jong &
Hien, 2006; Schock, Bollinger, & Collins, 2009). Successful mitigation
of infectious diseases in the wild demands that preventative or cura-
tive therapies demonstrate broad activity over as many genetic vari-
ants of the pathogen as possible, and developing mitigation
strategies that satisfy this criterion remains a major outstanding
research goal.
Batrachochytrium dendrobatidis is a highly infectious fungal patho-
gen responsible for the global decline in amphibians and a major
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driver of the current “amphibian extinction crisis” (reviewed in Gar-
ner et al., 2016). This pathogen comprises multiple deeply diverged
lineages and is capable of rapid evolution through extensive genomic
recombination (Farrer et al., 2011, 2013). Endemic hypovirulent lin-
eages of B. dendrobatidis have been identified including BdCAPE
(South Africa), BdCH (Switzerland), BdBrazil (Brazil) and a lineage
from Japan (Farrer et al., 2011; Goka et al., 2009; Rodriguez, Becker,
Pupin, Haddad, & Zamudio, 2014; Rosenblum et al., 2013; Schloegel
et al., 2012), although such endemic lineages may be implicated in
population declines in novel regions (e.g., BdCAPE in Mallorcan mid-
wife toads, Alytes muletensis; Doddington et al., 2013). However, it is
the globally distributed hypervirulent global panzootic lineage
(BdGPL) that is associated with phenomenal mass mortalities and
rapid population declines of amphibians around the world (Farrer
et al., 2011; Fisher et al., 2009; Olson et al., 2013). Isolates within
this lineage exhibit enormous and unpredictable variation in viru-
lence, even within a single host species exposed under laboratory
conditions (Farrer et al., 2011, 2013).
There is currently no cure for chytridiomycosis in the wild (re-
viewed in Garner et al., 2016). Given that amphibian communities
may be host to multiple B. dendrobatidis variants (Morgan et al.,
2007; Rodriguez et al., 2014) and that global movement of humans
and wildlife continues to transport the pathogen (Garner et al.,
2016), any prophylactic or curative treatment needs to be effective
against multiple B. dendrobatidis variants. Bacterial probiotics repre-
sent a promising tool to combat emerging infectious diseases in the
wild, including B. dendrobatidis (Bletz et al., 2013; Hoyt et al., 2015;
Rebollar et al., 2016). Laboratory and field studies have shown host-
associated bacterial communities protect amphibians from B. dendro-
batidis infection and that it is possible to artificially augment the
microbiota with probiotic bacteria to improve survivorship in
response to the pathogen (Becker et al., 2015; Bletz et al., 2013;
Harris, Lauer, Simon, Banning, & Alford, 2009; Jani & Briggs, 2014;
Kueneman et al., 2016; Muletz, Myers, Domangue, Herrick, & Harris,
2012; Walke et al., 2015). However, inhibitory capabilities of individ-
ual bacteria are not uniform across the variation presented by
B. dendrobatidis (Antwis, Preziosi, Harrison, & Garner, 2015; Bletz,
Myers, et al., 2017; Muletz-Wolz et al., 2017). In addition, previous
work has found either no (Becker et al., 2015) or weak evidence
(Bletz, Myers, et al., 2017) of a phylogenetic signal in the ability of
bacterial genera to inhibit a singular B. dendrobatidis isolate. How-
ever, a major gap in our understanding concerns whether some bac-
terial genera are more likely to show broad-spectrum inhibition
across a range of B. dendrobatidis isolates, allowing a more focused
search for effective amphibian probiotics.
Furthermore, the importance of a complex and diverse micro-
biota for resilience to infection has been repeatedly demonstrated
across a range of host taxa (e.g., Dillon, Vennard, Buckling, & Charn-
ley, 2005; Eisenhauer, Schulz, Scheu, Jousset, & Pfrender, 2013; van
Elsas et al., 2012; Matos, Kerkhof, & Garland, 2005). An alternative
strategy for probiotic development involves a “bacterial consortium”
approach, whereby multiple inhibitory bacterial strains are applied
simultaneously. Multispecies consortia can increase inhibition of
B. dendrobatidis growth through increased competition and the pro-
duction of emergent metabolites (Loudon et al., 2014; Piovia-Scott
et al., 2017) and may offer greater inhibitory capabilities across a
wider range of B. dendrobatidis isolates. However, the generality of
this pattern across multiple pathogen variants remains untested.
Addressing this shortfall in our understanding is critical for develop-
ing effective tools for the mitigation of emerging infectious diseases
in the wild.
Here, we extend previous work to quantify the ability of individ-
ual bacteria and cocultured bacterial consortia to demonstrate
broad-scale inhibition across a panel of B. dendrobatidis isolates.
First, we test 54 bacterial strains from 10 genera for inhibition
against a suite of 10 different BdGPL isolates to quantify: (i) varia-
tion among bacterial genera in ability to demonstrate broad-spec-
trum BdGPL inhibition; and (ii) variation among BdGPL isolates in
susceptibility to inhibition. Second, we quantify the relative efficacy
of using single bacterial strains or bacterial consortia to modify
B. dendrobatidis growth rates in vitro. Specifically, we investigate (iii)
whether consortia yield stronger inhibition than single bacterium
across three B. dendrobatidis isolates from two lineages (BdGPL and
BdCAPE); and (iv) whether genus-level diversity of a bacterial con-
sortium affects inhibitory capabilities.
2 | METHODS
2.1 | Taxonomic classification
In vitro challenges were conducted for 54 bacteria isolated from wild
Agalychnis spp. frogs in Belize (Antwis et al., 2014, 2015; Woodhams
et al., 2015) to screen for inhibitory capabilities against 10 BdGPL iso-
lates (Table 1, Figure 1). Batrachochytrium dendrobatidis is present in
the Maya Mountains from where these bacteria were collected,
although declines in Agalychnis hosts were not seen in this area (Kaiser
& Pollinger, 2012; R. E. Antwis, personal observation). Bacterial strains
belonged to 10 genera with 3–11 bacteria per genus (Table S1). Bacte-
ria were identified using colony PCR to amplify the 16S rRNA gene
(with primers 27F and 1492R) and sequenced at the University of
Manchester (Antwis et al., 2014). The forward and reverse sequences
were aligned for each bacterium and blasted against the NCBI data-
base (http://blast.ncbi.nlm.nih.gov/Blast.cgi). To calculate genetic dis-
tance among sequences, we aligned the sequences against the SILVA
reference database (Quast et al., 2013). We used the seqinr package
(Charif & Lobry, 2007) to import the aligned sequences and calculate
the pairwise genetic distances among bacterial strains.
Inhibition challenges were conducted using an in vitro absor-
bance-based growth inhibition assay adapted from Bell, Alford, Gar-
land, Padilla, and Thomas (2013), Woodhams et al. (2014) and
Becker et al. (2015). Bacteria were grown by adding 50 ll of frozen
stock bacteria (stored in 30% glycerol, 70% tryptone solution at
80°C) to 15 ml of 1% tryptone and incubating at 18°C for 36 hr
until turbid (three cultures per bacterial strain). Although cell density
has been shown to influence metabolite production in culture
(Yasumiba, Bell, & Alford, 2016), we decided not to count and adjust
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cell density prior to inhibition trials as subsequent addition of media
may alter the metabolite profiles already produced by cultures. In
addition, cultures were not grown in the presence of B. dendrobatidis
as multiple B. dendrobatidis isolates were tested in this study.
Turbid cultures were filtered through a 0.22-um sterile filter (Mil-
lipore, Ireland) to remove live cells, leaving only bacterial products
(including metabolites) in the filtrate. These were then combined
across the three cultures for a given bacterial strain and kept on ice
until B. dendrobatidis challenges were conducted. BdGPL (Table 1)
isolates were grown in 1% tryptone broth until maximum zoospore
production was observed (~3–4 days; ~1 9 106 zoospores ml1). As
with bacteria, three flasks per B. dendrobatidis isolate were grown
and then combined prior to challenges to minimize flask effect.
Zoospores were separated from sporangia by filtering through 20-
lm sterile filters (Millipore, Ireland). To conduct the absorbance-
based growth inhibition assays, 50 ll of bacterial filtrate and 50 ll
of B. dendrobatidis suspension were pipetted into 96-well plates.
Each B. dendrobatidis–bacteria combination was run in triplicate. Pos-
itive controls were included using 50 ll 1% tryptone instead of bac-
terial filtrate. Negative controls were included using 50 ll of sterile
tryptone and 50 ll of heat-treated B. dendrobatidis for each isolate.
Plate readings were taken using a 492-nm filter on initial construc-
tion of the challenge assays and every 24 hr for four subsequent
days.
For each measurement, data were transformed using the equa-
tion Ln(OD/(1-OD)) and a regression analysis was used to gain the
slope values for each sample over time. Slopes of triplicate replicates
for each B. dendrobatidis–bacteria combination were averaged, and
the slope of the negative controls subtracted. Total B. dendrobatidis
inhibition was calculated using the formula: Inhibition (%) = [1
(slope of sample/slope of control)] 9 100 to give an “inhibition
score.” A positive inhibition score represents inhibition of B. dendro-
batidis growth and a negative score indicates enhanced growth of
B. dendrobatidis. It should be noted that we did not use a nutrient-
depleted control in our experiments (Bell et al., 2013), which means
B. dendrobatidis inhibition relative to the controls may be slightly
underestimated.
2.2 | Bacterial consortium challenges
Three bacterial strains were then selected from each of five genera
(Chryseobacterium, Comamonas, Enterobacter, Staphlycoccus and Ste-
notrophomonas) based on their inhibition profiles; poor to medium
inhibitors were selected to determine whether combining these bac-
teria would improve their inhibitory capabilities (mean percentage
inhibition score of approximately 0 to +50; Figure 1). Bacteria were
grown individually until turbid and added to fresh tryptone either
individually (strains A, B and C of each genus separately) or as a tri-
ple (strains A, B and C of each genus together to form five single-
genus mixes or a combination of strains across genera to form multi-
genus consortia, with a total of 20 multigenus combinations tested).
For both individual and triple bacterial combinations, a total of 3 ml
TABLE 1 Batrachochytrium dendrobatidis isolates used in the study
Isolate Lineage Geographic Host species Collector Year
Phylogeny
screening
Consortium chal-
lenges
MG04 GPL Silver Mine, Western Cape, South
Africa
Amietia fuscigula Trenton
Garner
2010 X
CORN2.2 GPL Penhale Farm, Cornwall, UK Ichthyosaurus
alpestris
Trenton
Garner
2012 X
CORN2.3 GPL Penhale Farm, Cornwall, UK Ichthyosaurus
alpestris
Trenton
Garner
2012 X
CORN3.1 GPL Penhale Farm, Cornwall, UK Ichthyosaurus
alpestris
Trenton
Garner
2012 X
CORN3.2 GPL Penhale Farm, Cornwall, UK Ichthyosaurus
alpestris
Trenton
Garner
2012 X
AUL1.2 GPL Lac d’Aule, France Alytes obstetricans Matthew
Fisher
2010 X
AUL2 GPL Lac d’Aule, France Alytes obstetricans Matthew
Fisher
2010 X
IA2011 GPL Ibon Acherito, Spain Alytes obstetricans Matthew
Fisher
2011 X
MODS
28.1
GPL Mont Olia, Sardinia Discoglossus sardus Trenton
Garner
2010 X
JEL423 GPL Guabal, Panama Agalychnis lemur Joyce
Longcore
2004 X X
SFBC019 GPL Sellafield, Cumbria, UK Epidalea calamita Peter Minting 2010 X
TF5a1 CAPE Torrent des Ferrerets, Mallorca Alytes muletensis Matthew
Fisher
2007 X
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of bacteria were added to 12 ml of fresh 1% tryptone broth and left
to grow together for 12 hr. The volume of each bacterium added
depended on whether the consortium contained one or three bacte-
ria, and the volume was split evenly between the numbers of bacte-
ria added to each group. Following this, bacteria–B. dendrobatidis
challenges were conducted using the same methods as described
above against three B. dendrobatidis isolates (Table 1). Average inhi-
bition percentages for each consortium–B. dendrobatidis combination
were calculated as described above.
2.3 | Statistical analysis
All statistical analyses were conducted in the software R v.3.3.2 (R
Core Team 2016).
2.3.1 | Taxonomic group data
To quantify differences among genera in proportion of BdGPL iso-
lates inhibited (i.e., for those where inhibition score >0), we fitted a
binomial GLM with the proportion of the 10 BdGPL isolates each
bacterial strain inhibited as the response, and genus as a fixed
effect. We used the quasibinomial error structure as the model was
overdispersed (dispersion 6.4) and tested the model containing a
genus term with the reduced intercept-only model using a likeli-
hood ratio test.
To visualize the distribution of inhibition across bacterial strains
and B. dendrobatidis isolates, we constructed a heatmap using the
pheatmap package in R (Kolde, 2015). To quantify differences among
genera in the degree of inhibition (size of inhibition score), we fitted
F IGURE 1 Inhibition scores of 54 bacterial strains from 10 genera when tested against 10 BdGPL isolates. A positive value represents
inhibition of Batrachochytrium dendrobatidis growth and a negative value indicates enhanced growth of B. dendrobatidis. Estimates are derived
from a Bayesian mixed-effects model with bacterial strain nested within genus, and BdGPL isolate fitted as random effects. Points are
conditional modes of the individual bacterial strain random effects, marginalized with respect to BdGPL isolate. Error bars are 95% credible
intervals. Bacterial strains from the same genus are denoted by the same colour
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a hierarchical model in the R package MCMCglmm (Hadfield, 2010)
with the individual inhibition scores of each bacterial strain (n = 54)
for each BdGPL isolate (n = 10; total n = 540) as a Gaussian
response. We fitted both BdGPL isolate and bacterial strain ID
nested within bacterial genus as random effects. We also controlled
for genetic distance among bacterial strains by passing the bacterial
16S gene tree to the model as a phylogenetic random effect. We
use uninformative, parameter-expanded priors for the random
effects as detailed in Hadfield (2010). We ran models for a total of
100,000 iterations following a burn-in of 10,000 iterations and using
a thinning interval of 50. Inspection of model residuals from the fre-
quentist analogue of this model fitted in lme4 (Bates, Maechler,
Bolker, & Walker, 2015) revealed normally distributed residuals and
no evidence of heteroscedasticity. Rerunning models with stronger
priors has no effect on model results. Gelman–Rubin diagnostic of
Markov chains indicated adequate convergence, with all potential
scale reduction factors <1.01. We used Bayesian models here, rather
than a frequentist analogue, due to the ease of summarizing uncer-
tainty in point estimates of random effect conditional means using
95% credible intervals of Markov chain values. To calculate % vari-
ance in inhibition explained by BdGPL isolate, bacterial genus and
bacterial strain respectively, we extracted the variance components
from the variance–covariance matrix of the model above. We
expressed the variance of a component V as a percentage of the
total variance calculated as (VBdGPL + Vgenus + Vstrain + Vresidual). We
calculated both mean and 95% credible intervals using the posterior
samples from the model. To construct Figures 1 and 2, we extracted
the marginal means and 95% credible intervals for each bacterial
strain and BdGPL isolate, respectively. That is, the bacterial strain
modes are marginalized with respect to BdGPL, and vice versa, to
quantify whether the average scores for each BdGPL isolate or bac-
terial strain are significantly different from zero.
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F IGURE 2 Heatmap of inhibition across all 54 bacterial strains and all 10 Batrachochytrium dendrobatidis isolates. Bacterial strains have
been clustered according to phylogeny, and B. dendrobatidis isolates have been clustered according to their similarity in inhibition profiles
(dendrograms in left and top margins, respectively). Inhibition scores have been z-transformed across B. dendrobatidis isolates (rows) for each
particular bacterial strain. Bacterial row names include both genus and strain ID. Blue indicates low inhibition through to red, which indicates
high inhibition
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2.3.2 | Correlation between genetic distance and
inhibition
For each pair of bacterial strains, we calculated the correlation between
the inhibition scores for the ten B. dendrobatidis isolates. If more closely
related bacterial strains are more likely to have similar inhibition profiles,
there should be a negative correlation overall between genetic distance
and similarity of inhibition. To test this, we performed a Mantel test
using the genetic distance and inhibition score similarity matrices in the R
package “vegan” (Oksanen et al., 2015).
2.3.3 | Consortium data
To calculate the relative mean inhibition of single-genus vs. multi-
genus consortia, we fitted a mixed model in MCMCglmm with inhibi-
tion as a Gaussian response, consortium type as a two-level factor
and a random effect of B. dendrobatidis isolate using uninformative
priors. To calculate whether consortia exhibited stronger inhibition
than the mean of their individual strains, we constructed a binary
variable with an outcome of 1 if a consortium’s inhibition was
greater than the single strain mean, and 0 if equal to or lower. We
fitted this as a response in a binary GLMM with consortium type as
a fixed effect, B. dendrobatidis as a random effect and using uninfor-
mative priors. Neither model exhibited signs of autocorrelation and
Geweke statistics for both models indicated convergence (Geweke,
1992). We calculated mean genetic distance among members of con-
sortia using the genetic distance measures outlined above. We fitted
a Bayesian GLM where the percentage inhibition of a consortium
was a function of the interaction between the genetic distance
among consortia members and the B. dendrobatidis isolate identity.
Genetic distance was standardized prior to model fitting to remove
the correlation between main effects and interactions.
2.3.4 | Consortium randomizations
We used a randomization approach to probe the relative effectiveness
of single bacteria, single-genus consortia and multigenus consortia
(hereafter “probiotic types”) for modifying the growth rates of B. den-
drobatidis. These randomizations used the “Taxonomic Group” and
“Consortium” inhibition data from above to explore three different
scenarios relevant to the application of probiotics to B. dendrobatidis.
For each iteration of a randomization, we randomly selected a B. den-
drobatidis isolate and then extracted the inhibition scores of a ran-
domly chosen single bacterial strain, single-genus consortium and
multigenus consortium. After 1,000 iterations, we calculated (i) the
proportion of times a multigenus consortium yielded higher inhibition
than a single-genus consortium; (ii) the proportion of times a multi-
genus consortium yielded higher inhibition than a single bacterial
strain; and (iii) the probability that a multigenus, single-genus or single
bacterial strain would yield at least 50% inhibition, which we classed
as strong inhibition. This approach is more powerful than simply calcu-
lating differences in group means of each probiotic type, as group
means can be skewed by large individual values, and therefore be
misleading with respect to the efficacy of a particular strategy if the
mean of that group is not reflective of the true variance in the data.
However, we report group means alongside these statistics where
appropriate for comparison. We derived 95% confidence intervals for
each test statistic by performing 10,000 bootstrap samples with
replacement from the test distributions. The three scenarios we tested
were as follows:
Scenario 1: Averaged over all B. dendrobatidis isolates: For each
iteration, we randomly selected a B. dendrobatidis isolate and then
randomly selected both a single-genus and a multigenus consortium.
A single bacterial strain score was then selected randomly from one
of the members of the multigenus consortium.
Scenario 2: B. dendrobatidis-specific scores: To investigate the
potential for the effectiveness of consortia to differ depending on
B. dendrobatidis isolate, we repeated the randomization as in Scenario
1 but performed 1,000 iterations for each B. dendrobatidis isolate
separately.
Scenario 3: Sequential B. dendrobatidis exposure: Finally, we
examined the ability of the three probiotic types to inhibit two
B. dendrobatidis isolates encountered in series by randomly selecting
two of the three B. dendrobatidis isolates. We assumed that the two
isolates are not encountered simultaneously as co-occurrence of two
B. dendrobatidis isolates may modify their growth rates and/or a bac-
terial strain’s ability to inhibit them. For each iteration, we selected a
random multigenus and single-genus consortium, followed by a ran-
domly selected single strain member from the multigenus consor-
tium. Individual inhibition scores for these three groups were then
extracted for both selected B. dendrobatidis isolates (i.e., probiotic ID
was kept consistent over both pathogen isolates). We calculated the
probability that the multigenus consortium would yield superior inhi-
bition to the single-genus consortium and single bacterial strain
across both B. dendrobatidis isolates, and the probability that all
three probiotic types would yield >50% inhibition.
3 | RESULTS
3.1 | BdGPL inhibition within and among bacterial
genera
We assayed the ability of 54 bacterial strains from 10 genera to modify
the growth rates of 10 BdGPL isolates. Mean inhibition scores ranged
from 100 (complete inhibition of growth) to 225 (strong facilitation of
growth). There were no significant differences among genera in mean
proportion of BdGPL isolates inhibited (binomial GLMM; v29 ¼ 8:12,
p = .52; Figure 1; Table 2). Six strains from four genera showed at least
weak inhibition across all 10 BdGPLs, whilst five strains from four gen-
era facilitated the growth of all 10 B. dendrobatidis isolates (Table S1).
We did not find a significant correlation between genetic distance and
similarity of inhibition profiles (Mantel test r = .027, p = .77).
We detected considerably more variation in inhibition scores
among bacterial strains within genera than among genera (Figure 1).
Variation among bacterial strains within genera explained 87.9%
[95% credible interval (CRI) 80.25%–94.47%] of the variation in
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BdGPL inhibition scores compared to just 0.6% [0.007%–3.8%] for
bacterial genus. BdGPL isolate explained 3.9% [0.1%–8.7%] of the
variation in inhibition scores. Heatmap hierarchical clustering of inhi-
bition scores revealed two isolates that demonstrated predominantly
enhanced growth in the presence of bacterial filtrates (JEL423 and
AUL2; Figure 2). In one case, B. dendrobatidis isolates from similar
locations (i.e., CORN isolates from Cornwall) exhibited similar
clustering of inhibitions scores, whereas in another case (i.e., AUL
isolates from the Pyrenees) these showed markedly different
inhibition fingerprints (Figure 2).
3.2 | Multistrain consortia as tools for pathogen
mitigation
Consortia containing strains from multiple genera exhibited signifi-
cantly higher mean inhibition scores compared to single-genus con-
sortia when marginalizing with respect to B. dendrobatidis isolate
(multigenus consortia mean inhibition: 36.88%; single-genus consor-
tia mean: 16.9%; 95% CRI of difference 4.12%–36.52%,
pMCMC = 0.02; Figure 3). Multigenus consortia had a 61% probability
of demonstrating stronger inhibition than the mean of their single
composite bacterial strains, which was significantly higher than the
corresponding probability for single-genus consortia (26.6%, mean
difference 39.4% [95% credible interval 11.2%–65.1%],
pMCMC = 0.01). Mean genetic distance among members of multi-
genus consortia was significantly higher than among members of sin-
gle-genus consortia (multigenus mean distance = 0.45, single-genus
mean = 0.11, t = 15.5, p < .001). Consortia with higher mean
genetic distance elicited significantly higher inhibition scores for
B. dendrobatidis isolates BdCAPE TF5a1 and BdGPL MODS28.1
(pMCMC = 0.009), but not for BdGPL SFBC019, which had a
significantly different slope to the other two B. dendrobatidis isolates
(Figure 4, pMCMC = 0.01).
TABLE 2 Mean proportion of 10 BdGPL isolates for which at
least weak inhibitory capability was observed, averaged over all
bacterial strains in a genus
Genus
Number of
Isolates
Mean Proportion
BdGPL Inhibition 95% CI
Acinetobacter 6 0.33 0.1–0.64
Chryseobacterium 8 0.50 0.25–0.75
Citrobacter 3 0.67 0.24–0.95
Comamonas 4 0.70 0.32–0.94
Enterobacter 7 0.73 0.44–0.92
Microbacterium 4 0.40 0.1–0.76
Sanguibacter 3 0.63 0.22–0.94
Serratia 6 0.47 0.19–0.76
Staphylococcus 4 0.73 0.35–0.96
Stenotrophomonas 9 0.49 0.25–0.73
95% CI: 95% confidence intervals from an overdispersion-corrected bino-
mial GLM.
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F IGURE 3 Inhibition scores for single-genus (SG) and multigenus (MG) consortia across three Batrachochytrium dendrobatidis isolates
(BdGPL MODS28.1, BdGPL SFBC019 and BdCAPE TF5a1). A positive value represents inhibition of B. dendrobatidis growth, and a negative
value indicates enhanced growth of B. dendrobatidis. Points have been jittered for display purposes
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3.3 | Probiotic consortium randomizations
Scenario 1: Our randomization tests revealed that multigenus con-
sortia gave higher inhibition than single-genus consortia in 69.4%
of cases when averaging over all B. dendrobatidis isolates (null
expectation 50%, pRAND<0.001). Multigenus consortia were more
likely to produce inhibition greater than 50% (strong inhibition)
(38.1% of iterations) compared to single-genus consortia (13.9% of
iterations, p < .001) and outperformed a randomly chosen single
bacterial strain in 61% of cases (null expectation 50%,
pRAND<0.001). Mean inhibition for all multigenus consortia across
all B. dendrobatidis isolates was 36.7%, compared to 16.47% for sin-
gle-genus consortia.
Scenario 2: When considering B. dendrobatidis isolates individu-
ally, multigenus consortia outperformed single-genus consortia and
single bacterial strains for only two of the three isolates (BdGPL
MODS28 and BdCAPE TF5a1, but not for BdGPL SFBC019;
Figure 5a). This pattern was also evident when determining
the probability of yielding >50% inhibition by consortia (Fig-
ure 5b).
Scenario 3: We also tested the ability of both multigenus and
single-genus consortia to inhibit the growth of two different B. den-
drobatidis isolates in series, as individuals in a single location may
be exposed to multiple variants of a pathogen (Goka et al., 2009;
Jenkinson et al., 2016; Rodriguez et al., 2014; Schloegel et al.,
2012), or strong spatial structure of the pathogen and high host
dispersal may expose individuals to multiple pathogen variants con-
secutively. Applying the same multigenus consortium to two differ-
ent randomly chosen B. dendrobatidis isolates in series achieved
stronger inhibition than single-genus consortia in 49.4% of cases
(null expectation 25%, pRAND<0.001). This compared to only 7.9%
of cases where single-genus consortia exhibited superior inhibition
for both B. dendrobatidis isolates. Multigenus consortia exhibited
strong inhibition (>50%) for both isolates in 14.7% of cases, com-
pared to zero cases where single-genus isolates did so. Applying a
single bacterial strain instead of a single-genus or multigenus con-
sortium resulted in strong inhibition for both B. dendrobatidis iso-
lates in only 4% of cases (Figure 5c). The full results of these
randomizations, including confidence intervals for tests, can be
found in Table S2.
4 | DISCUSSION
The principal objectives of this study were twofold (i) to determine
whether certain genera of bacteria are better able to inhibit a broad
range of BdGPL isolates; and (ii) to examine the relative effective-
ness of single bacteria and bacterial consortia to inhibit multiple iso-
lates of B. dendrobatidis. We found no evidence of variation among
bacterial genera in their ability to exhibit broad-range inhibition
across multiple BdGPL isolates. There was considerable within-genus
variation in inhibitory capabilities of bacteria compared to between-
genus variation, meaning genus is not a reliable indicator of anti-
B. dendrobatidis capabilities across multiple isolates of this pathogen.
Furthermore, our data suggested consortia can provide superior
B. dendrobatidis inhibition compared to individual bacteria and that
this is contingent on consortium taxonomic diversity, but critically
this pattern is not uniform across pathogen isolates. Our results have
important implications for developing effective strategies for design-
ing probiotic therapies to mitigate lethal infectious disease.
4.1 | BdGPL inhibition within and among bacterial
genera
We found no evidence of systematic variation among bacterial gen-
era in their ability to inhibit multiple BdGPL isolates. In our data, the
principal source of variance in inhibition was among bacterial strains,
with the number of strains demonstrating broad-spectrum facilitation
of BdGPL being approximately equal to the number exhibiting broad-
scale inhibition of the pathogen. These data support previous work
suggesting B. dendrobatidis inhibition capability is distributed widely
across bacterial genera (Antwis et al., 2015; Becker et al., 2015;
Bletz, Myers, et al., 2017); several strains demonstrated at least
weak inhibition for all 10 BdGPLs but were spread across multiple
genera with no clear pattern. That there is clear functional redun-
dancy among genera in this host-protective trait suggests it is not
prudent to focus on any one genus in the search for beneficial probi-
otics (Becker et al., 2015), as highly divergent microbial communities
can still possess similar functional traits (e.g., Bletz et al., 2016; Bletz,
Perl, 2017).
We identified one BdGPL isolate that was significantly prone to
inhibition (08MG04) and a further two isolates that demonstrated
F IGURE 4 Relationship between mean
genetic distance among consortium
members and Batrachochytrium
dendrobatidis inhibition score. We detected
a significant positive relationship between
genetic distance and inhibition percentage
for BdCAPE TF5a1 and BdGPL MODS28.1
but not BdGPL SFBC019. Fitted lines and
shaded areas are mean and 95%
confidence intervals from a linear model fit
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strong resistance to inhibition (i.e., facilitated growth; AUL2 and
JEL423). The phenomenon of BdGPL growth facilitation has been
described previously for single pathogen isolates (Becker et al.,
2015; Bell et al., 2013), but crucially, our results suggest that a bac-
terial strain’s ability to facilitate the growth of B. dendrobatidis
extends across a broad suite of pathogen isolates. Thus, facilitation
of B. dendrobatidis growth is not simply a rare phenomenon arising
from specific BdGPL/bacterial combinations, and different BdGPL
isolates may differ systematically in their growth rates when
exposed to bacterial filtrates (see also Muletz-Wolz et al. 2017). It
is unclear why some bacterial strains facilitate B. dendrobatidis
growth, but one likely explanation is that certain bacterial metabo-
lites can act as growth substrates or facilitators for fungi (Garbaye,
1994; Hardoim et al., 2015). In addition, different bacterial metabo-
lites may alter the abiotic environment (e.g., pH) to confer different
growth rates (Romanowski et al., 2011) or hormesis may occur
whereby the growth of B. dendrobatidis is facilitated at low or inter-
mediate concentrations of particular bacterial products (Bell et al.,
2013).
Further research is required to determine whether a BdGPL iso-
lates’ susceptibility to inhibition or facilitation correlates with viru-
lence, and how genotypic traits associated with the pathogen map
on to inhibition profiles and taxonomic traits of bacteria. It would
also be valuable to further explore the effects of coculturing bacte-
ria with B. dendrobatidis prior to inhibition challenges, which may
influence anti-B. dendrobatidis capabilities (Becker et al., 2015). In
particular, B. dendrobatidis isolates that elicit particularly strong
metabolites from bacteria (i.e., B. dendrobatidis isolates that are
readily inhibited) could be used to prime probiotic bacteria to make
these more effective at inhibiting other more resistant B. dendroba-
tidis isolates, such as AUL2 and JEL423 in this study.
4.2 | Consortium-based approaches to combatting
fungal pathogens
Our results revealed that the relationship between taxonomic
diversity of a probiotic consortium and its ability to inhibit B. den-
drobatidis growth was not consistent across B. dendrobatidis iso-
lates. Multigenus consortia outperformed both single-genus
consortia and single bacterial strains in B. dendrobatidis inhibition,
and were far more likely to produce strong inhibition of 50% or
greater, but this is true only for two of the three pathogen vari-
ants. Previous work has demonstrated a link between consortium
species richness and B. dendrobatidis inhibition but only for a single
pathogen isolate (Loudon et al., 2014; Piovia-Scott et al., 2017).
Our data suggest that this pattern may not be general, with
marked variation among pathogen isolates in their susceptibility to
multigenus consortia.
That said, the general relationship (for two of the three pathogen
variants) between inhibition and consortium diversity was in the
expected direction; low community relatedness (i.e., high community
dissimilarity) and high species richness both increase the resistance
of a bacterial community to pathogenic “invaders” (Eisenhauer,
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F IGURE 5 Randomization results examining the relative efficacy
of different probiotic strategies. (a) the probability of multigenus
consortia (MGC) yielding higher inhibition compared to single-genus
consortia (SGC) or a single bacterial strain (Single); (b) the probability
of MGC, SGC or single bacteria yielding inhibition > 50% when
applied to each of three Batrachochytrium dendrobatidis isolates; (c)
the probability of an individual consortium type yielding >50%
inhibition when applied to two randomly chosen B. dendrobatidis
isolates in series
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Scheu, & Jousset, 2012; Eisenhauer et al., 2013; Jousset, Schmid,
Scheu, & Eisenhauer, 2011). That multigenus consortia can provide
superior inhibition for some pathogen variants is suggestive of syner-
gistic effects, whereby the combined pool of metabolites from multi-
ple bacteria inhibits B. dendrobatidis more strongly than the
individual strains (Loudon et al., 2014). Superior inhibition from con-
sortia, rather than single strains, may arise as a by-product of the
interference competition over resources created by coculture
(Scheuring & Yu, 2012). Bacteria that are weak inhibitors when used
individually (as in this study) could increase the overall inhibitory
power of a consortium by creating a competitive environment that
favours greater production of antifungal compounds.
We found that one of the three B. dendrobatidis isolates (BdGPL
SFBC019) was not susceptible to inhibition from more diverse con-
sortia as exhibited the other two pathogen variants (BdCAPE TF5a1
and BdGPL MODS 28.1). That B. dendrobatidis isolate can alter the
strength of the relationship between consortium diversity and inhibi-
tion is a highly novel finding. BdGPL SFBC019 appears largely resis-
tant to inhibition irrespective of whether individual bacteria or
consortia are used, with individual bacterial inhibition scores that
were often negative (Figure 3). This suggests resistance to inhibition
from single strains may not necessarily be overcome by the putative
synergistic effects from coculturing bacteria, in the same way that
total microbial communities (along with other anti-B. dendrobatidis
factors associated with the skin) of amphibians may not always be
resistant to particular variants of the pathogen (Antwis & Weldon,
2017). The underlying cause for this variation is unclear as our data
suggest this variation in consortia-based inhibition does not appear
to correlate with B. dendrobatidis lineage. In addition, the results of
the single strain challenges with 10 BdGPL isolates showed all four
isolates from one locality in the UK (CORN isolates; Table 1; Fig-
ure 2) showed similar levels of inhibition across all bacterial strains,
whereas the two isolates from the same locality in France (AUL
isolates; Table 1; Figure 2) exhibited markedly different inhibition
profiles. This suggests even pathogen isolates collected from the
same host species and locality have the potential to exhibit markedly
different responses to bacterial probiotics. More work is required to
determine the relative inhibition profiles of multiple B. dendrobatidis
isolates challenged with single- and multibacterial probiotics across a
spectrum of diversity and to determine the mechanisms driving the
responses of B. dendrobatidis variants to these.
In the study presented here, some metabolites (and other bacterial
products) will have been carried over from bacterial strains whilst con-
structing single- and multispecies consortia, and it is also possible that
after 12 hr of coculture, the proportions of bacteria in the multispecies
consortia were not equal. Thus, it would be beneficial to determine
how inhibition profiles of mixed-species consortia alter over time and
whether this can be optimized for the mitigation of wildlife disease.
Similarly, understanding the response of the host microbiome to inoc-
ulation by probiotics, and concurrent factors that determine the long-
evity of probiotics on the skin of amphibians, would provide significant
steps forward in developing effective treatments.
4.3 | Conclusion
Our work has highlighted that different isolates of a lethal wildlife
pathogen can vary in their susceptibility to probiotic bacteria, mean-
ing we cannot expect probiotic effectiveness to be uniform across
the genetic or phenotypic landscape of the pathogen. That said,
higher diversity (both in terms of richness and phylogeny) of probiotic
consortia may provide greater protective capabilities against patho-
gens than individual bacteria, although some B. dendrobatidis isolates
may be largely resistant to the majority of bacterial probiotics, and
using bacterial consortia may not overcome this. These patterns are
informative with respect to potential strategies for the application of
bacterial probiotics to mitigate B. dendrobatidis and other wildlife
pathogens. Conservationists might not always know which particular
B. dendrobatidis variant is infecting a local population, preventing tar-
geted application of known strong inhibitors for that variant (Muletz-
Wolz et al. 2017), and both time and expense may prevent the estab-
lishment of such a database de novo if a probiotic intervention is
required rapidly. Therefore, we must employ strategies that maximize
the chance of successful inhibition in the absence of perfect knowl-
edge of the pathogen. Although multigenus consortia did not always
outperform single-genus consortia or single bacteria strains, our data
did reveal that these consortia have the highest probability of
“strong” inhibition of >50% if applied “naively” without knowledge of
the pathogen variant. This finding is important; human-mediated
spread of B. dendrobatidis through the amphibian trade (Fisher & Gar-
ner, 2007) means we cannot assume that local populations will be
exposed to only one pathogenic variant. Future work will expand this
study to test multigenus consortia against a broader range of patho-
gen isolates to determine the generality of this pattern, in addition to
identifying the inhibitory capabilities of consortia constructed from
bacteria with medium to strong inhibition profiles. It would be partic-
ularly interesting to combine whole-genome sequencing of the patho-
gen with inhibition data from single bacterial strains and consortia to
assess whether closely related pathogen isolates are more likely to
show similar responses, or lack thereof, to bacterial consortia. Despite
the potential merits of multigenus consortia for mitigating single and
multiple B. dendrobatidis variants, it remains to be determined how
readily these consortia will be able to colonize the host skin in vivo.
This is crucial for quantifying how applicable inhibition measures
derived in vitro are to real-world scenarios. Additionally, although we
tend to treat bacterial inhibition scores as fixed traits, this ignores the
ability of genetic recombination among B. dendrobatidis lineages to
modify the relationship between bacterial metabolites and pathogen
growth rates. Even the application of probiotics themselves may rep-
resent a strong selective pressure favouring genetic variants of
B. dendrobatidis that lack susceptibility to those probiotics. Although
several trials have demonstrated the potential for probiotic prophy-
laxis against B. dendrobatidis, we still lack the requisite data to mea-
sure selection caused by those trials on the pathogen. In vitro
experimental evolution assays between pathogen and bacteria may
prove the most powerful means for detecting such patterns.
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